Tianshui Zhongxing Bio-Technology continues wealth management with idle funds

Tianshui Zhongxing Bio-Technology Co., Ltd. announced its latest activities in entrusted wealth management, detailing a recent redemption and a new subscription using idle self-owned funds. On October 28, 2025, the company redeemed its "Southwest Securities Tianli No. 4 Collective Asset Management Plan," involving CNY 5,000, achieving an annual yield of 2.90% and a profit of CNY 145.00. The principal and returns were received by October 31, 2025.

Concurrently, the company subscribed to a new "Southwest Securities Tianli No. 4 Collective Asset Management Plan" product on October 28, 2025, also with an investment of CNY 5,000. This fixed-income collective asset management plan, managed by Southwest Securities Co., Ltd., continues Tianshui Zhongxing Bio-Technology's approved strategy to deploy up to CNY 60,000 of idle funds, approved by the board on March 21, 2025. The investment period for the new plan is for a maximum of 12 months, with funds allowed to be rolled over within the approved limit.

As of the announcement date, Tianshui Zhongxing Bio-Technology holds CNY 38,000 in entrusted wealth management products, reflecting its active management of idle capital. The company had previously extended the investment period for its "Shanyuanjin No. 206 Private Securities Investment Fund" by one year on April 20, 2025.